| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.008 | 15.456 | 23.950 | 17.859 | 8.020 | 12.444 | 15.609 | 13.673 | 18.312 | 17.271 |
| Total Income - EUR | 13.008 | 15.458 | 23.950 | 17.859 | 8.020 | 12.444 | 15.609 | 13.673 | 18.312 | 22.248 |
| Total Expenses - EUR | 14.962 | 14.202 | 17.056 | 17.181 | 18.993 | 17.761 | 17.845 | 18.405 | 21.385 | 21.710 |
| Gross Profit/Loss - EUR | -1.954 | 1.256 | 6.895 | 677 | -10.973 | -5.317 | -2.236 | -4.732 | -3.073 | 538 |
| Net Profit/Loss - EUR | -2.340 | 1.102 | 6.655 | 499 | -11.054 | -5.442 | -2.392 | -4.869 | -3.256 | -21 |
| Employees | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medlix S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 175 | 69 | 68 | 1.829 | 1.555 | 1.292 | 1.035 | 809 | 578 | 347 |
| Current Assets | 1.335 | 4.459 | 10.519 | 9.625 | 3.426 | 8.301 | 7.676 | 8.293 | 9.485 | 9.233 |
| Inventories | 26 | 166 | 919 | -530 | 0 | 460 | 495 | 1.172 | 1.672 | 2.080 |
| Receivables | 0 | 0 | 109 | 1.400 | 2.136 | 6.714 | 6.680 | 6.701 | 6.681 | 3.225 |
| Cash | 1.309 | 4.293 | 9.490 | 8.755 | 1.291 | 1.127 | 501 | 420 | 1.132 | 3.928 |
| Shareholders Funds | -22.634 | -21.301 | -14.286 | -13.525 | -23.797 | -28.788 | -30.541 | -35.505 | -38.653 | -38.458 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.143 | 25.830 | 24.873 | 24.979 | 28.779 | 38.381 | 39.252 | 44.606 | 48.715 | 48.038 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Medlix S.r.l.